Latest News
1 AI Biotech Stock That Just Scored a Major Milestone
Barchart - Sat Oct 5, 7:15AM CDT
Barchart
Sat Oct 5, 7:15AM CDT
Down over 85% from all-time highs, Recursion Pharmaceuticals is an AI-powered biotech company that aims to accelerate the drug discovery process.
Ex-Chinook team launches Borealis Biosciences with $150-million from Novartis, Versant
The Globe and Mail - Thu Aug 22, 6:30AM CDT
The Globe and Mail
Thu Aug 22, 6:30AM CDT
Group behind one of biggest Canadian biotech takeovers unveils latest addition to Vancouverโs teeming life sciences sector
1 AI Growth Stock With 54% Upside Potential
Barchart - Thu Mar 14, 7:30AM CDT
Barchart
Thu Mar 14, 7:30AM CDT
Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Hereโs a closer look at the biotech stock that has garnered investments from both AI chipmaker Nvidia and ARKK fund manager Cathie Wood.
Why Regeneron Investors Shouldn't Fear Its Patent Cliff
Motley Fool - Thu May 26, 2022
Motley Fool
Thu May 26, 2022
New treatments will step in to replace blockbuster eye medication EYLEA.
Judicial Panel Rejects Bayer Monsanto Attempt to Thwart Fair Settlement for Roundup-Cancer Victims
PR Newswire - Wed Oct 20, 2021
PR Newswire
Wed Oct 20, 2021
/PRNewswire/ -- A panel of judges has shut the door on an attempt by Bayer (OTCMKTS: BAYZF) and its Monsanto subsidiary to quietly settle a group of lawsuits...